Mode
Text Size
Log in / Sign up

Wiskott-Aldrich syndrome with IgA nephropathy requires early recognition and multidisciplinary managementKidney and immune issues linked to rare blood disorders in a boy

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider early recognition and multidisciplinary management for Wiskott-Aldrich syndrome with renal involvement.

This publication is a narrative review and case presentation describing a 10-year-old boy with Wiskott-Aldrich syndrome (WAS)/X-linked thrombocytopenia and IgA nephropathy, with supporting data from the IPINet registry of 117 patients with WAS/X-linked thrombocytopenia. The case patient had a homozygous c.599+5G>A WAS variant, near-complete absence of megakaryocytes on bone marrow studies, reduced complement levels, elevated immunoglobulins, and multiple autoantibodies including antiglomerular basement membrane, antineutrophil cytoplasmic antibodies, and antinuclear antibodies. Kidney biopsy showed IgA nephropathy (Oxford M0 E0 S0 T1 C0) with 30% interstitial fibrosis. The authors synthesize that dysregulated T- and B-cell function in WAS/X-linked thrombocytopenia promotes autoantibody formation, contributing to renal injury. They note that registry data remain essential for guiding prognosis, monitoring complications, and informing therapeutic strategies, including hematopoietic stem cell transplantation. Limitations include the single-case design and reliance on registry data without reported follow-up or comparator groups. Practice relevance emphasizes early recognition, genetic confirmation, and multidisciplinary management.

This case presentation describes a 10-year-old boy diagnosed with Wiskott–Aldrich syndrome and X-linked thrombocytopenia. Medical teams reviewed his specific case alongside data from the IPINet registry, which includes 117 patients with these disorders. The boy had kidney biopsy results showing IgA nephropathy and significant scarring in his kidney tissue. Genetic testing confirmed a specific variant linked to his condition. His bone marrow showed a near-complete absence of megakaryocytes, and blood tests revealed reduced complement levels and elevated immunoglobulins. Multiple autoantibodies were also detected in his blood.

The boy exhibited signs of renal involvement, glomerulonephritis, and autoimmune manifestations. These findings highlight the complex nature of these rare disorders. The review notes that dysregulated T- and B-cell function in these conditions promotes autoantibody formation, which can contribute to kidney injury. This biological mechanism helps explain the link between the blood disorders and the kidney problems observed in this patient.

Readers should understand that registry data remain essential for guiding prognosis and monitoring complications in these patients. Early recognition and genetic confirmation are important steps in managing these conditions. Multidisciplinary management is emphasized as a key strategy for these patients. Hematopoietic stem cell transplantation is mentioned as a potential therapeutic strategy. This information comes from a case presentation with a literature review and is not practice-changing evidence.

What this means for you:
Early recognition and genetic confirmation are important for managing kidney and immune issues in these rare blood disorders.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
BackgroundWiskott–Aldrich syndrome (WAS) is a rare X-linked primary immunodeficiency caused by mutations in the WAS gene, characterized by thrombocytopenia, eczema, recurrent infections, and immune dysregulation. Its milder form, X-linked thrombocytopenia (XLT), exhibits variable autoimmune manifestations. Renal involvement, particularly glomerulonephritis, is uncommon but clinically significant.Case presentationWe report a 10-year-old boy presenting with severe thrombocytopenia, hyporegenerative anemia, nephritic-range proteinuria, and hematuria, alongside multiple autoantibodies including antiglomerular basement membrane, antineutrophil cytoplasmic antibodies, and antinuclear antibodies. His complement levels were reduced and immunoglobulins elevated. Kidney biopsy revealed IgA nephropathy (Oxford M0 E0 S0 T1 C0) with 30% interstitial fibrosis. Bone marrow studies demonstrated near-complete absence of megakaryocytes. The patient’s family history was notable for thrombocytopenia in the mother and younger brother. Genetic testing confirmed a homozygous c.599+5G>A WAS variant, consistent with XLT.Literature reviewTo contextualize these findings, data from the literature, including the IPINet registry (117 patients with WAS/XLT), were reviewed. WAS patients frequently exhibited invasive infections and diverse autoimmune manifestations, including hemolytic anemia, vasculitis, inflammatory bowel disease, arthritis, nephropathy, and celiac disease.DiscussionDysregulated T- and B-cell function in WAS/XLT promotes autoantibody formation, contributing to renal injury. IgA nephropathy is the predominant glomerular pathology, mediated by circulating immune complexes containing aberrantly glycosylated IgA1.ConclusionThis case illustrates the broad spectrum of autoimmunity in WAS/XLT, highlighting the potential for renal involvement. It emphasizes the importance of early recognition, genetic confirmation, and multidisciplinary management. Registry data remain essential for guiding prognosis, monitoring complications, and informing therapeutic strategies, including hematopoietic stem cell transplantation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.